Cite
HARVARD Citation
McClure, C. et al. (2022). Safety and tolerability of Pau d′ Arco (Tabebuia avellanedae) for primary dysmenorrhea: A single-arm, open-label trial on adults ages 18–45. Advances in integrative medicine. 9 (3), pp. 159-166. [Online].